Skip to content

Lirio

1 viewer · 30d

Total raised

$1.6M

+$1.6M this year

1 filing since 2026 · latest SAFE filed

Cumulative raised
LAST ROUND
SAFE · $1.6M
ROUNDS
1
INVESTORS
10
FOUNDED
N/A
HQ
Knoxville, TN
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
1

AI overview

Updated

Lirio is a digital health company that combines behavioral science with AI to personalize patient and member outreach for healthcare organizations. Its platform identifies the behavioral, emotional and cognitive barriers keeping an individual from a health action, selects a tailored intervention, and orchestrates the message, channel and timing for each person. The system learns from millions of interactions across deployments to improve subsequent outreach. Customers include health systems, payers, retail pharmacy and life sciences companies; a diabetes intervention launched with Cone Health in 2024 and a life-sciences product debuted in 2025.

What sets it apart

Pairs a behavioral-science intervention library with reinforcement-learning AI so each patient receives an individually selected nudge rather than a segment-level campaign message, which the company reports as roughly four times more effective than standard health messaging.

Funding history

1 round
SAFE+2Apr 27, 2026
Form D
+$1.6M$1.6M total

Latest SEC filings

via EDGAR · CIK 0001696371
Form D · Apr 27, 2026View on EDGAR

Products

1 tracked

Precision Nudging

Patient engagement / digital health platform

A personalized outreach engine that delivers individually tailored behavioral nudges to patients and health plan members, driving enrollment, engagement, adherence and care navigation on top of an organization's existing communication infrastructure.

  • Identifies individual behavioral, emotional and cognitive barriers
  • Selects a customized behavioral-science intervention per person
  • Optimizes message content, channel and send timing
  • Learns and improves from millions of prior interactions

Links

WebsiteLinkedInSEC EDGAR filings